the adma biologics ( gi ) family of biologics is a multicenter, biopharmapharma industry that is a major global health care provider. it is a multicenter, biopharma industry that has been a pioneer in the development and development of the immune globulin therapy. we are now joining our team with the author, a member of the gi family of biologics, to discuss our current status and progress in our research and practice. we will also discuss the current status of our research and research efforts.